Works with your normal sleep-wake cycle
ROZEREM is a prescription melatonin receptor agonist medication. ROZEREM is thought to promote sleep by working with your normal sleep-wake cycle, which is regulated by the body's internal clock.
Clinical studies in adults and older patients
In clinical studies of adults and older patients with chronic insomnia, ROZEREM reduced the time it took to fall asleep.
Not likely to leave you feeling groggy the next day
Until you know how you will react to ROZEREM, avoid hazardous activities like driving and operating machinery.
Effect on mobility, memory functions, or middle-of-the-night balance in older adults
In a study in older adults (n=33), a single nighttime dose of ROZEREM did not affect middle-of-the-night balance, mobility, or memory. However, there is no available information on the effects of multiple doses of ROZEREM, and the effects on night balance in the elderly cannot be definitively known from this study.
ROZEREM is not a controlled substance. There was no evidence of abuse, dependence, or withdrawal in studies.
The American Geriatrics Society (AGS) Beers Criteria
The AGS Beers Criteria is a valuable resource for healthcare professionals about the safety of prescribing drugs for older adults.
ROZEREM is not listed as a potentially inappropriate medication for use in older adults in the AGS Beers Criteria.
Talk to your healthcare professional to see if ROZEREM is right for you.